Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06845306

The Use of Indocyanine Green Near-infrared Fluorescence for Bowel Perfusion Quantitative Assessment in Order to Prevent Anastomotic Leakage in Colorectal Surgery

Indocyanine Green Near-infrared Fluorescence Bowel Perfusion Quantitative Assessment to Prevent Anastomotic Leakage in Colorectal Surgery: a Multicentre, Randomised, Controlled Study

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
1,268 (estimated)
Sponsor
Vadim Kuznetsov · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Anastomotic leakage (AL) is a serious complication after surgery for colon cancer, leading to a significant increase in mortality.Intraoperative fluorescence imaging using indocyanine green has proven to be a feasible and reproducible technique for real-time perfusion assessment. An increasing number of studies are being published on the use of indocyanine green (ICG) fluorescence imaging in colorectal cancer surgery, showing promising results. Therefore, we propose conducting a multicenter, randomized controlled trial to investigate the potential use of quantitative assessment of near-infrared fluorescence imaging with indocyanine green (ICG) to prevent anastomotic leaks during colorectal surgery.

Conditions

Interventions

TypeNameDescription
DRUGICG-guided bowel perfusion assessmentICG will be injected before anastomosis is created, to quantitatively assess the perfusion status of the bowel.
OTHERConventional Bowel Anastomosis groupconventional perfusion assessment

Timeline

Start date
2025-06-01
Primary completion
2026-07-01
Completion
2026-09-01
First posted
2025-02-25
Last updated
2025-02-25

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT06845306. Inclusion in this directory is not an endorsement.